MAPK3 and ovarian carcinoma: TRPM7 downexpression decreases the phosphorylation of p-Akt in ovarian cancer cells and lung fibroblasts and also decreases the phosphorylation of p-ERK1/2 in breast cancer cells [8, 33, 34].